3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 - Names and Identifiers
Name | 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide
|
Synonyms | AZD2014 AZD2014(Vistusertib) 3-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide 3-{2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-N-methylbenzamide 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide 3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014
|
CAS | 1009298-59-2
|
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 - Physico-chemical Properties
Molecular Formula | C19H17ClN2O3S
|
Molar Mass | 388.87 |
Density | 1.231 |
Melting Point | 233-237oC |
Water Solubility | Chloroform (Slightly), Methanol (Slightly) |
Solubility | DMSO 11 mg/mL Water <1 mg/mL Ethanol <1 mg/mL |
Appearance | Shape Solid Color Light Yellow |
pKa | 14.45±0.46(Predicted) |
Storage Condition | -20°C Freezer |
Use | AZD2014 is a new mTOR inhibitor with IC50 of 2.8 nM. Highly selective action on various PI3K subtypes (α/β/γ/δ). |
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 - Risk and Safety
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 - Introduction
AZD1981 is an effective, selective CRTh2 (DP2) receptor antagonist with an IC50 of 4 nM, which is more than 1000 times more selective than acting on 340 other enzymes and receptors (including DP1).
Last Update:2022-10-16 17:30:56
3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide AZD2014 - Biological activity
Vistusertib (AZD2014) is a new type of mTOR inhibitor, IC50 is 2.8 nM in cell-free test; It has high selectivity for various PI3K subtypes (α/β/& gamma;/& delta;). At a concentration of 1 μM, there is no or weak binding force for most kinases. AZD2014 can induce proliferation inhibition, apoptosis, cell cycle arrest and autophagy in HCC cells, and has anti-tumor activity.
Last Update:2024-04-09 20:48:19